Literature DB >> 22012294

Quality of life in chronic urticaria: a survey at a public university outpatient clinic, Botucatu (Brazil).

Maria Regina Cavariani Silvares1, Maria Rita Parise Fortes, Hélio Amante Miot.   

Abstract

OBJECTIVE: To evaluate the impact of chronic urticaria on quality of life of outpatients through the university questionnaire Dermatology Life Quality Index (DLQI).
METHODS: Survey of the impact on quality of life caused by chronic urticaria, using the DLQI questionnaire validated for the Portuguese language. Patients were interviewed during visits to a specialized outpatient clinic between May 2009 and May 2010 at a Brazilian public service (Botucatu-SP). DLQI scores were analyzed according to the following subgroups: age, gender, education, disease duration, and presence of angioedema.
RESULTS: We interviewed 100 patients with chronic urticaria. There was a female predominance (86%), mean age 41.8 years, mean disease duration of 6 years, and angioedema occurrence in 82% of patients. The mean DLQI score was 13.5, characterized by serious impact on quality of life, higher than Hansen's disease, psoriasis, atopic eczema, and basal cell carcinoma. The presence of angioedema was associated with higher scores: 14.5 x 9.9 (p < 0.01). Female patients reported greater impact on clothing, while male patients reported treatment interference with work and study (p < 0.05).
CONCLUSION: Chronic urticaria seriously compromises the quality of life of patients evaluated at a university service in Brazil, particularly of patients with angioedema.

Entities:  

Mesh:

Year:  2011        PMID: 22012294     DOI: 10.1590/s0104-42302011000500018

Source DB:  PubMed          Journal:  Rev Assoc Med Bras (1992)        ISSN: 0104-4230            Impact factor:   1.209


  12 in total

1.  Clinical manifestations and quality of life in hidradenitis suppurativa patients: survey of participants from an internet support group.

Authors:  Isabel Greco Tavora; Gabriela Cabral Bissoli; Hélio Amante Miot; Juliano Vilaverde Schmitt
Journal:  An Bras Dermatol       Date:  2019-07-29       Impact factor: 1.896

2.  Translation into Portuguese language (Brazil), transcultural adaptation and validation of the quality of life questionnaire in female pattern hair loss (WAA-QoL-BP).

Authors:  Gisele Keiko Machado Shimizu; Gláucia Ferreira Wedy; Luiza Vasconcelos Schaefer; Paulo Müller Ramos; Hélio Amante Miot
Journal:  An Bras Dermatol       Date:  2018 Sep-Oct       Impact factor: 1.896

3.  Quality of life index in autoimmune bullous dermatosis patients.

Authors:  Mariana Álvares Penha; Joyce Godoy Farat; Hélio Amante Miot; Sílvia Regina Catharino Sartori Barraviera
Journal:  An Bras Dermatol       Date:  2015 Mar-Apr       Impact factor: 1.896

4.  Impact of chronic urticaria on the quality of life of patients followed up at a university hospital.

Authors:  Gabriela Andrade Coelho Dias; Gisele Viana Pires; Solange Oliveira Rodrigues do Valle; Sérgio Duarte Dortas; Soloni Levy; Alfeu Tavares França; Ilaria Baiardini; Walter Giorgio Canonica
Journal:  An Bras Dermatol       Date:  2016 Nov-Dec       Impact factor: 1.896

5.  Quality of life in men diagnosed with anogenital warts.

Authors:  Caio Cavassan de Camargo; Maria Paula Barbieri D'Elia; Helio Amante Miot
Journal:  An Bras Dermatol       Date:  2017 May-Jun       Impact factor: 1.896

6.  The Burden of Chronic Urticaria from Brazilian Patients' Perspective.

Authors:  Maria-Magdalena Balp; Nilcéia Lopes da Silva; Jeffrey Vietri; Haijun Tian; Luis F Ensina
Journal:  Dermatol Ther (Heidelb)       Date:  2017-07-26

7.  Psychometrican analysis and dimensional structure of the Brazilian version of melasma quality of life scale (MELASQoL-BP).

Authors:  Camila Fernandes Pollo Maranzatto; Hélio Amante Miot; Luciane Donida Bartoli Miot; Silmara Meneguin
Journal:  An Bras Dermatol       Date:  2016 Jul-Aug       Impact factor: 1.896

Review 8.  Position statement for the use of omalizumab in the management of chronic spontaneous urticaria in Indian patients.

Authors:  Kiran Godse; Murlidhar Rajagopalan; Mukesh Girdhar; Sanjiv Kandhari; Bela Shah; Prashant N Chhajed; Sushil Tahiliani; D S Krupa Shankar; Vijay Somani; Vijay Zawar
Journal:  Indian Dermatol Online J       Date:  2016 Jan-Feb

9.  Omalizumab substantially improves dermatology-related quality of life in patients with chronic spontaneous urticaria.

Authors:  A Y Finlay; A P Kaplan; L A Beck; E N Antonova; M-M Balp; J Zazzali; S Khalil; M Maurer
Journal:  J Eur Acad Dermatol Venereol       Date:  2017-07-19       Impact factor: 6.166

10.  Suppression of wheal and flare in histamine test by the main H1 antihistamines commercialized in Brazil.

Authors:  Helena Maciel-Guerra; Mariana Álvares Penha; Marília Formentini Scotton Jorge; Ricardo da Silva Libório; Ana Cláudia Nazareno Dos Anjos Carrijo; Maria Rita Parise-Fortes; Hélio Amante Miot
Journal:  An Bras Dermatol       Date:  2018-03       Impact factor: 1.896

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.